Overview

A class action lawsuit has been filed against Evolv Technologies Holdings, Inc. (“Evolv” or the “Company”) (NASDAQ: EVLV) and certain of the Company’s former and current senior executive officers alleging violations of the federal securities laws.  The Evolv class action lawsuit is brought on behalf of all persons and entities who purchased or otherwise acquired Evolv securities between August 19, 2022, and October 30, 2024, both dates inclusive (the “Class Period”).  Investors have until December 31, 2024, to seek appointment as lead plaintiff in the Evolv class action lawsuit.

Evolv is a security technology company that utilizes artificial intelligence-based screening designed to help create safer experiences.  The Company’s solutions and services are designed to capture relevant visitor data customers can leverage to inform their security operations.  The Company’s key market categories include education, healthcare, sports, and live entertainment.  The Company principally derives revenue from (1) subscription arrangements generally accounted for as operating leases, (2) the sale of products, inclusive of Software as a Service and maintenance, and (3) professional services.

The Evolv class action lawsuit alleges that material misstatements in the Company’s financial statements were prepared for the periods between the second quarter of 2022 and the second quarter of 2024 relating to Evolv’s revenue recognition and other reported metrics that are a function of revenue.

*          *          *

If you purchased or otherwise acquired Evolv securities between August 19, 2022, and October 30, 2024, both dates inclusive, and you wish to serve as lead plaintiff in this lawsuit, we encourage you to submit your information to DiCello Levitt LLP via the form on this page. 

You can also contact DiCello Levitt partner Brian O’Mara by calling (888) 287-9005 or at [email protected]. 

The deadline to apply to the Court to serve as a lead plaintiff in the Evolv class action lawsuit is December 31, 2024.